ERBB2 and breast carcinoma: Gene expression profiling studies have shown that HER2-negativehormone receptor-positive breast cancer can be classified into twobiologically distinct subtypes: luminal A and luminal B.2,3 Moreover, the importance of Ki67 in breastcancer has become increasingly apparent after Cheang et al.